ID: ALA2235235

Max Phase: Preclinical

Molecular Formula: C19H16O7

Molecular Weight: 356.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc(O)c2c(=O)cc(-c3ccccc3OC(C)=O)oc2c1OC

Standard InChI:  InChI=1S/C19H16O7/c1-10(20)25-14-7-5-4-6-11(14)15-8-12(21)17-13(22)9-16(23-2)18(24-3)19(17)26-15/h4-9,22H,1-3H3

Standard InChI Key:  YHAOIBQNQISMJX-UHFFFAOYSA-N

Associated Targets(non-human)

Avian myoblastosis virus polyprotein II 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 356.33Molecular Weight (Monoisotopic): 356.0896AlogP: 3.11#Rotatable Bonds: 4
Polar Surface Area: 95.20Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.88CX Basic pKa: CX LogP: 2.61CX LogD: 2.48
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.57Np Likeness Score: 1.15

References

1. Phosrithong N, Samee W, Ungwitayatorn J.  (2012)  3D-QSAR studies of natural flavonoid compounds as reverse transcriptase inhibitors,  21  (5): [10.1007/s00044-011-9570-z]

Source